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Eight optochin susceptible (OptS) -hemolytic (viridans) streptococci were 1 
characterized at the molecular level. These isolates showed phenotypic characteristics 2 
typical of both viridans streptococci and Streptococcus pneumoniae. Comparison of the 3 
sequence of housekeeping genes from these isolates with those of S. pneumoniae, 4 
Streptococcus mitis, Streptococcus oralis, and Streptococcus pseudopneumoniae suggested 5 
that the OptS isolates corresponded to streptococci of the mitis group. Besides, the OptS 6 
streptococci were negative by the Gen-Probe AccuProbe Pneumococcus test, and 7 
hybridized with specific pneumococcal probes (lytA and ply) but also with ant, a gene not 8 
present in most S. pneumoniae strains. Moreover, the isolates were insoluble in 1% sodium 9 
deoxycholate but completely dissolved in 0.1% deoxycholate. Sequence analysis of the lytA 10 
gene revealed that  the OptS streptococci carried lytA alleles characteristic of those present 11 
in the nonpneumococcal streptococci of the mitis group. The determination of the partial 12 
nucleotide sequence embracing the atp operon encoding the F0F1 H+-ATPase, indicated that 13 
the Opt susceptibility of the isolates was due to the acquisition of atpC, atpA and part of 14 




Streptococcus pneumoniae (the pneumococcus) is an important cause of morbidity and 2 
mortality worldwide, remaining a major etiological agent of community-acquired pneumonia, 3 
meningitis and acute otitis media (3). Three phenotypic characteristics are used for identification 4 
of the pneumococcus among -hemolytic (viridans) streptococci: optochin (Opt) susceptibility, 5 
bile (sodium deoxycholate; Doc) solubility, and reaction with type-specific antisera (21). 6 
Although their colony morphology can be very similar, the -hemolytic streptococci of the mitis 7 
group (SMG) as Streptococcus mitis or Streptococcus oralis, are classically Opt-resistant (OptR), 8 
insoluble in 1% Doc, and nontypeable (21).  9 
In most countries, the Opt-susceptibility test still remains the only clinical test carried out 10 
for the identification of the pneumococcus, although Doc solubility is also currently inspected in 11 
many U. S. Laboratories. It is well known that the typical Opt-susceptibility of pneumococci is 12 
due to the characteristics of the F0 complex of its F0F1 H
+-ATPase (12), an enzyme essential for 13 
the viability of this organism (13). The primary roles of this enzyme are to create a proton 14 
gradient with the energy provided by ATP hydrolysis and to maintain the intracellular pH via 15 
proton extrusion (24). Hydrolysis of ATP on the cytoplasmic F1 sector (, , , , and  subunits) 16 
drives proton transport through the F0 cytoplasmic membrane sector (a, b, and c subunits) by 17 
long-range conformational changes (1, 34, 36). The activity of the F0F1 ATPase of S. pneumoniae 18 
is pH-inducible and is regulated at the level of initiation of transcription (24).  19 
Resistance to Opt or other amino-alcohol antimalarial drugs (i.e., quinine, mefloquine) in 20 
pneumococcus has been reported as a consequence of point mutations that change amino acid 21 
residues located in either one of the two transmembrane -helices of the c subunit or one of the 22 
two last -helices of the a subunit (8, 12, 25, 28, 33). This fact suggests that the mentioned -23 
 4 
helices of these subunits interact and that the mutated residues are important for the structure of 1 
the F0 complex and, consequently, for proton translocation. Although several S. pneumoniae Opt
R 2 
isolates have been reported (19, 27, 32, 33, 39), to the best of our knowledge there are only three 3 
reports describing OptS SMG (6, 23, 26), but only a single OptS SMG has been characterized as 4 
having a recombinant structure in the genes encoding the F0F1 H
+-ATPase, this is, it had acquired 5 
the atpC, atpA and part of atpB from S. pneumoniae (23). 6 
A new member of the mitis group (Streptococcus pseudopneumoniae) has been recently 7 
described (4). Isolates of these species exhibit an OptR phenotype when they are incubated under 8 
an atmosphere of increased CO2 , but Opt susceptibility increases in the presence of O2 (4). In this 9 
sense, this report recommended the use of  a CO2-enriched atmosphere for this test to prevent 10 
misidentification of SMG Opt-variants as truly pneumococci. The same authors described S. 11 
pseudopneumoniae as Doc-insoluble, although solubility in 0.1% Doc has been recently 12 
documented (20). It has also been found that some SMG, including S. pseudopneumoniae strains, 13 
carry atypical alleles of the lytA gene (encoding the major pneumococcal autolysin LytA), and 14 
most of them are insoluble in 1% Doc but completely dissolved when 0.1% Doc was used (20). 15 
This behavior is in agreement with the finding that 1% Doc (but not 0.1% Doc) inhibited the 16 
activity of the LytA-like amidases from SMG, whereas the LytA enzyme synthesized by typical 17 
pneumococci was not affected by the detergent (30). 18 
In this work we have gained more insights into the knowledge of the OptS phenotype in 19 
SMG by characterizing eight OptS SMG isolated during 2002 at the Spanish Pneumococcal 20 
Reference Laboratory, and have determined a partial sequence of the atp operon from two S. 21 
pseudopneumoniae strains.  22 
 23 
MATERIALS AND METHODS 24 
 5 
 1 
 Bacterial strains, growth conditions, and determination of optochin sensitivity. The 2 
bacterial strains used in this work are listed in Table 1. Unless otherwise stated, streptococci were 3 
grown in Todd-Hewitt broth supplemented with 0.5% yeast extract at 37ºC without shaking. For 4 
determination of the Opt sensitivity, each isolate was cultured onto Mueller-Hinton agar plates 5 
(Difco) supplemented with 5% defibrinated sheep blood (BA plates). Several colonies were 6 
suspended in liquid culture and 107 CFU were applied to BA plates in which 5-g OPT disks of 6 7 
mm (Becton Dickinson Microbiology Systems) were placed. After overnight incubation at 37ºC 8 
either in 5% CO2 or O2 atmospheres, inhibition zones around the disk were measured. MICs were 9 
determined by the agar dilution method as recommended by the Clinical Laboratory Standards 10 
Institute (29) except that plates were incubated either in 5% CO2 or ambient atmosphere. MIC 11 
was defined as the lowest concentration of drug that inhibited visible growth. S. pneumoniae 12 
ATCC strains 6303, S. pneumoniae R6, S. mitis NCTC 12261T, S. oralis NCTC 11427T, and two 13 
S. pseudopneumoniae strains (CCUG 49455T and CCUG 48465) were used as controls. Opt was 14 
purchased from Sigma Chemical, St. Louis. 15 
 Deoxycholate solubility tests.  Aliquots (0.5 ml) of exponentially growing cultures received 16 
50 l of 1 M potassium phosphate buffer (pH 8.0) and 50 l of a 10% or 1% Doc solution in 17 
water. The mixtures were incubated for up to 15 min at 37ºC. Lysis was followed by decrease of 18 
the turbidity. The strains that lysed with 1% Doc were designated as Doc+. This was the case for 19 
true pneumococcal isolates. However, those SGM that lysed with 0.1% Doc but not with 1% Doc 20 
were named Doc/ . 21 
 Gene-Probe (AccuProbe). For detection of the ribosomal RNA genes, the AccuProbe S. 22 
pneumoniae Culture Identification test (Gen-Probe, San Diego, Calif.) was used according to the 23 
 6 
manufacturer’s instructions with four colonies from an overnight culture on 5% BA plates. 1 
 PCR amplification and DNA sequence determination and analysis. PCR 2 
amplifications were performed using 0.51 units of Thermus thermophilus thermostable DNA 3 
polymerase (Biotools), 0.1 g of chromosomal DNA, 1 M (each) of the synthetic 4 
oligonucleotide primers, 0.2 mM of each dNTP in a final volume of 50 l, in the buffer 5 
recommended by the manufacturers. Amplification was achieved with an initial cycle of 1 to 5 6 
min denaturation at 94ºC, 2530 cycles of 1 min of denaturation at 94ºC, 1 min of annealing at 7 
55ºC, and 1 to 4 min of polymerase extension at 72ºC, with a final 8 min extension at 72ºC and 8 
slow cooling at 4ºC. PCR products were purified using MicroSpinTM S400 HR columns 9 
(Amersham-Pharmacia-Biotech) and sequenced on both strands with an Applied Biosystems 10 
Prism 377 DNA sequencer. The following atp-operon regions were amplified. Fragments of 11 
about 3 kb from SMG isolates 1504, 1237, 1956, 2859, and 3137 with oligonucleotides pepti101 12 
(23) and atp110 (24), located in spr1284 and in the gene of the delta subunit of the F0F1 H
+-13 
ATPase, respectively. Fragments of 1935 bp from isolates 578,  2410, and 3198 were amplified 14 
with oligonucleotides pepti368 (5’-CCAGGTTTCCGTCATTTTGAAAC-3’) and atpBEND (5’-15 
GGCTTCTCCTAGCTGATCGATATAC-3’), located in spr1284 and in atpB, respectively. To 16 
amplify the atpCAB region from S. pseudopneumoniae strains, PCR fragments were obtained by 17 
using oligonucleotides atpWO (23) and atpBEND. The upstream atpC regions from those strains 18 
were amplified with oligonucleotides spr1370-196 (5´- ATTCCTTGCCTTGCTCTCAGCAG-3’) 19 
and spr1368END-2 (5’- GACACAATTTCTAGGTTATAACTGG-3’), located in spr1370 and 20 
downstream spr1368, respectively, yielding fragments of about 3 kb. PCR fragments were 21 
sequenced with the same oligonucleotides and with several internal oligonucleotides In addition, 22 
direct sequencing of chromosomal DNAs using oligonucleotide atpCorf2 (24) was performed. 23 
 7 
PCR amplification and sequencing of the lytA alleles from SGM strains were carried out using 1 
the conditions and oligonucleotide primers described elsewhere (20). Multilocus sequence typing 2 
(MLST) was carried out exactly as described elsewhere (11) with the tools provided by the 3 
MLST Web site for the molecular characterization of pneumococci (http://www.mlst.net). 4 
Multiple sequence alignments were created with PILEUP (9) or CLUSTALW (38). Pairwise 5 
evolutionary distances (PEDs) (estimated number of substitutions per 100 bases) were 6 
determined using the DISTANCES program (9) with the Kimura two-parameter distance correction 7 
(18). Sequence comparisons were carried out by running the BLAST program (2) and the 8 
EMBL/UniProtKB databases as well as preliminary genomic data for S. pneumoniae 670 and S. 9 
mitisT (The Institute for Genomic Research website at http://www.tigr.org) and for other 10 
pneumococcal strains (The Sanger Institute; http://www.Sanger.ac.uk/Projects/S_pneumoniae).  11 
 Southern blot identification of strains.  Restriction fragments carrying lytA and ply 12 
(pneumolysin) DNA probes and PCR products carrying the ant probe (a homolog of genes 13 
encoding aminoglycoside adenylyltransferases) were obtained as described previously (14, 23). 14 
Probes were labeled with the Phototope-Star Detection Kit (New England Biolabs). Southern blot 15 
and hybridization followed the manufacturer’s instructions. 16 
 Nucleotide sequence accession numbers. The sequences of the atpCAB genes reported here 17 
have been deposited in the EMBL/GenBank/DDBJ databases. The lytA alleles have been 18 
assigned accession numbers AM113498, AM113499, AM113501, AM113502, AM1113505, the 19 
housekeeping fragments are accession numbers  DQ659935 to DQ659964, and DQ665241 to 20 






Phenotypic characteristics of OptS SMG. The Spanish Pneumococcal Reference 4 
Laboratory receives pneumococcal isolates for typing purposes and antibiotic resistance 5 
surveillance. Isolates are routinely confirmed to be S. pneumoniae, by means of the Opt-6 
susceptibility and Doc solubility tests. Among the isolates received during 2002, 2.4% (78 out of 7 
3240) showed any discrepancy in those tests and did not show hybridization with the AccuProbe. 8 
Among the 78 AccuProbe-negative isolates, 11 exhibited a clear Opt inhibition zone ( 12 mm) 9 
in the presence of 5% CO2. Eight of these 11 isolates were chosen for further studies (Table 1). 10 
Phenotypic characterization of these OptS SGM using the Rapid ID 32 STREP kit (Bio Merieux, 11 
La Balme les Grottes, France) system classified them as S. oralis. This was not completely 12 
unexpected since it is documented that phenotypic characterization is of limited value for 13 
identification of many species of nonhemolytic streptococci, and particularly, of SMG (16). 14 
As previously reported (4), S. pseudopneumoniae showed Opt susceptibility (zones of 15 
inhibition 14 mm) with Opt disks when the test was carried out in ambient air and Opt 16 
intermediate resistance in a CO2-enriched atmosphere. Unexpectedly, a similar reaction was also 17 
observed for S. pneumoniae R6 (Table 1), making difficult to evaluate the significance of the 18 
results. As it remains unclear whether incubation in CO2, as recommended in
 the Manual of 19 
Clinical Microbiology (35), or ambient atmosphere, as recommended by the manufacturers of Opt 20 
test disks, is optimal for the identification of pneumococci, we decided to establish the Opt 21 
susceptibility of various strains following the standard procedures used to determine the MIC. 22 
The Opt MIC values were always higher in the presence of 5% CO2 than in ambient air. The 23 
lower Opt susceptibility in an atmosphere of increased CO2 may be related to the activation of the 24 
 9 
promoter of the atp operon in response to acid that would produce a 2-fold increase in the amount 1 
of the F0F1 H
+-ATPase (24), increasing the Opt MIC by titration. 2 
The eight isolates showed a Doc+/– phenotype, this is, they did not lyse in the presence of 1% 3 
Doc, but were solubilized when 0.1% Doc was used (not shown). Furthermore, they autolysed 4 
after a prolonged incubation at 37°C confirming previous results obtained with strains 578 and 5 
1504 that synthesize a defective, but functional, LytA autolysin (20). These results taken together 6 
strongly suggested the presence of an atypical lytA allele not only in strains 578 and 1504, but 7 
also in the other SMG (see below). 8 
Genetic relatedness of the OptS SMG. The eight OptS, Doc+/–, AccuProbe-negative SMG 9 
isolates were inspected to determine the presence of pneumococcal specific genes such as ply or 10 
lytA (not shown). Southern blot hybridization experiments showed that all eight strains harbored 11 
both genes (Fig. 1 and unpublished observations). Quite surprisingly, however, they also 12 
hybridized with the ant probe, a gene not normally present in S. pneumoniae but that is found in 13 
S. mitis and S. oralis (5).  14 
Taking into account these results, the genetic relationship between the OptS SMG and other 15 
strains was investigated by using MLST as previously suggested (15). Partial sequences of gdh, 16 
gki, recP, and spi were determined from the OptS SMG and S. pseudopneumoniae strains. The 17 
concatenated allelic profiles were compared to those present at the pneumococcal MLST Web 18 
site (15) and to that of S. mitis NCTC 12261T (The Institute for Genomic Research; 19 
http://www.tigr.org). The eight OptS SMG grouped with the nontypeable, nonpneumococcal 20 
isolates, as did S. pseudopneumoniaeT and S. mitisT strains. Six out of eight OptS SMG formed a 21 
clade with S. mitis NCTC 12261T (Fig. 2) . 22 
Genetic analysis of lytA alleles carried by OptS SMG. The lytA alleles from the isolates 23 
studied here were PCR amplified and sequenced, excepting those from isolates 578 and 1504, 24 
 10 
and the two S. pseudopneumoniae strains that had been already reported (20). Three new 1 
different lytA alleles were found (data not shown). Strains 1237 and 2859 carried the same lytA 2 
allele, whereas alleles from strains 3137 and 2410 differed from each other and from those 3 
included in the EMBL database. The lytA1956 and lytA3198 alleles were identical, respectively, to 4 
those present in the OptS SMG 1504 and 3072 previously reported (20). All sequences matched 5 
the signatures characteristic of lytA alleles from nonpneumococcal SMG including the 6-bp 6 
deletion located near the 3’ end of the gene (20) and explained why the OptS SMG studied here 7 
showed a Doc+/– phenotype (Table 1). 8 
Susceptibilities of isolates to optochin and organization and sequence of the atp 9 
chromosomal region. Nucleotide sequences of 1499-bp fragments containing the atpC, atpA, 10 
part of atpB, and 114 bp located upstream of atpC from the 10 SMG, including the two strains of 11 
S. pseudopneumoniae, were determined. The sequences from strains 578 and 1504 were identical 12 
to those from strains 1237 and 3137, respectively. Besides, all of the isolates showed identical 13 
sequences from nucleotide position 77 to 1217, which included the atpC and atpA genes as well 14 
as the first 138 bp of atpB (Fig. 3A). Moreover, sequence comparisons with those included in the 15 
EMBL database (21 March 2006, last date accessed) also showed that the atpC gene of SMG was 16 
identical to that of strain R6 (Accession numbers Z26851, AE008506, and AF368465) and to 15 17 
other entries from pneumococcal strains. Moreover, we also found that the atpA alleles of R6 and 18 
the OptS SMG only differed at three positions and always at the third position of the 19 
corresponding codon: T to C transitions at codons 24 and 220 (positions 421 and 1009 in Fig. 20 
3A), and a C to T transition at codon 84 (position 601 in Fig. 3A). None of these differences 21 
produced changes in the predicted primary sequence of the ATPase a subunit.  22 
Upstream of atpC (nucleotide positions 1–114) and downstream of nucleotide 138 of atpB 23 
(nucleotide positions 1218-1499) the sequences of SMG clearly diverged from that of the 24 
 11 
pneumococcal strain R6 (Fig. 3A). Moreover, sequence divergence was found among the OptS 1 
SMG in those regions being more evident upstream of atpC (PEDs up to 15.6%) (Fig. 3B) than at 2 
the 3’ end of atpB (PEDs lower than 6%) (Fig. 3F). Besides, evolutionary divergence ranged 3 
between 3.6 (for the S. pseudopneumoniae strains) and 17.8% (for strains 1504, 1956, 2410, and 4 
3137) when compared with the S. pneumoniae R6 strain (Fig. 3B). It should be noted that, in this 5 
region, strain 1504 and their relatives were much more evolutionarily related to S. mitisT (PED, 6 
6.43%) than to S. pneumoniae, although other OptS SMG clearly diverged (PEDs higher than 7 
11%) from both S. pneumoniae R6 and S. mitisT (Fig. 3B). S. oralisT was only distantly related to 8 
the OptS SMG (PEDs higher than 19%). Taking together all these results, it is assumed that the 9 
OptS SMG acquired their atpC and atpA genes from S. pneumoniae via horizontal transfer. 10 
Early reports had suggested that an insertion sequence (IS) element was located immediately 11 
upstream of the S. pneumoniae atp operon (12). Nucleotide sequencing has confirmed now the 12 
presence in this region of the pneumococcal chromosome of a copy of IS1239 (spr1367/SP1515) 13 
in every strain tested, namely, R6 (17), TIGR4 (37), G54 (10), 670 (http://www.tigr.org), and 14 
Spain23F-1, OXC14 and INV104B (http:// www.Sanger.ac.uk/Projects/S_pneumoniae) (data not 15 
shown). On the other hand, Martín-Galiano et al. recently reported that, in S. mitisT and S. 16 
oralisT, atpC is preceded by a gene highly similar to the S. pneumoniae spr1284/SP1429 17 
putatively encoding a protease (23). In S. pneumoniae, however, atpC and spr1284 are located 65 18 
kb apart approximately (23, 37). Moreover, both genes are apparently arranged in an inverted 19 
position in S. mitisT and S. oralisT with respect to S. pneumoniae (where spr1284 is located 20 
downstream of atpC). PCR amplification and nucleotide sequencing with appropriate 21 
oligonucleotide primers showed that, with the significant exception of the S. pseudopneumoniae 22 
strains, the gene spr1284 is located immediately upstream of atpC in the OptS SMG (Fig. 4). In S. 23 
pseudopneumoniae strains the gene spr1368 is located immediately upstream of atpC, which is 24 
 12 
equivalent to the gene organization in S. pneumoniae isolates but lacking the spr1367 copy of 1 
IS1239 (Fig. 4).  2 
 3 
DISCUSSION 4 
 The chromosomal organization of the atp operon region in S. pneumoniae, S. mitis, S. 5 
pseudopneumoniae and OptS SMG (Fig. 4) and the nucleotide sequences of the atpC-atpA-atpB 6 
regions, strongly suggest a recombinational origin for the eight OptS isolates analyzed in this 7 
work. This recombination resulted in the acquisition of a region of about 1.3 kb that included the 8 
complete atpC and atpA genes, and of 200–300 bp of atpB from S. pneumoniae. The same region 9 
was involved in the interchanges yielding the OptR S. pneumoniae strain M222 (12) and the  OptS  10 
S. mitis isolate 1162/99 (23), suggesting that the reconstitution of a functional F0F1 H
+-ATPase 11 
requires a b subunit with a N-terminus compatible with the a subunit and a C-terminus 12 
compatible with the  subunit. Besides, the gene organization upstream of atpC appears to be 13 
quite variable depending of the particular species and/or isolate studied. The comparison of the 14 
genomic regions of S. pneumoniae and S. mitis embracing the atp operon revealed the existence 15 
of significant differences between both species with an obvious loss of synteny (Fig. 4B). Most of 16 
these differences were related with genomic rearrangements suggesting frequent events of 17 
inversion and/or translocation of either individual genes or clusters of genes. It has been proposed 18 
that the observed genomic plasticity of the pneumococcal genome (7) may be related, at least in 19 
part, with the abundant presence of ISs and repeat elements such as those named BOX (22) and 20 
RUP (Repeat Unit of Pneumococcus) (31). As shown in Fig. 4B, transposases, RUPs and/or BOX 21 
elements were very frequently placed at the boundaries of the translocated/inverted DNA regions. 22 
We propose that one of such genomic rearrangements might be responsible for the differences 23 
 13 
observed in the genes located upstream of atpC in the closely related, OptR/OptS SMG. It is not 1 
known if there is any advantage for selecting for OptS SMG, but the involvement of the F0F1 H
+-2 
ATPase in the maintenance of the intracellular pH and of the membrane potential (24) suggests a 3 
relation between Opt susceptibility and the adaptation of  S. pneumoniae to the different habitats 4 
in which it causes infection.  5 
 The eight OptS SMG examined in this study represent a kind of streptococci that could not 6 
be classified as S. pneumoniae on the basis of being AccuProbe-negative and from their location 7 
in the phylogenetic tree constructed with housekeeping genes (Fig. 2). However, those isolates 8 
carry at least two pneumococcal virulence determinants (lytA and ply), and it was found that all of 9 
them perform an atypical bile solubility behavior, according with the genetic characteristics of 10 
their lytA alleles. At least seven of them were associated with disease and all were penicillin-11 
resistant. These data, and the description of three SMG isolates from United Kingdom associated 12 
with respiratory diseases carrying also lytA and ply (40), reflects the genetic interchange that is 13 
taken place among SMG, and between SMG and S. pneumoniae in nature.      14 
 Currently most clinical laboratories depend on the Opt susceptibility test for S. 15 
pneumoniae identification. Accordingly, the eight OptS SMG described in this work were 16 
identified as S. pneumoniae by the clinical laboratories that had sent them to the reference 17 
laboratory. Since misidentification of OptS SMG as S. pneumoniae may have significant 18 
implications for the management of patients, to perform at least two tests for the identification of 19 
S. pneumoniae, i.e., Opt susceptibility and bile solubility should be a must. Nevertheless, the 20 
results presented here, together with other previous reports of Opt-variant and/or Doc-variant 21 
phenotypes in SMG strains, reflect the importance of describing accurately the conditions used 22 
for both tests, that is, CO2 atmosphere composition and percentage of Doc, respectively. 23 
 14 
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FIG. 1. Southern blot hybridization of streptococcal isolates by hybridization with ply and ant-1 
specific probes. Chromosomal DNAs were cleaved with ClaI (A), and EcoRV plus NcoI (B), and 2 
the fragments were separated in 1% agarose gels. Mw, biotinylated DNA ladder. The gel was 3 
blotted and the blot was probed with biotinylated DNA as follows: insert of plasmid pJCP191 4 
containing the ply gene, and a PCR fragment from S. pneumoniae 3870 containing most of the 5 
ant gene.  6 
FIG. 2. Dendogram of genetic relationships between the SMG examined in this study (that are 7 
boldfaced and labeled with an asterisk) an other streptococcal isolates. The dendrogram was 8 
constructed from housekeeping gene sequence data by using the neighbor-joining method. Only 9 
bootstrap confidence values 70% are shown. NT and ST denote nontypeable SGM and sequence 10 
type, respectively (11). The scale represents the number of nucleotide substitutions per site.  11 
FIG. 3. Polymorphism in the atpC, atpA and atpB genes of OptS SMG. A, The nucleotides 12 
present at each polymorphic site are shown for S. pneumoniae R6 (Spn), but for the other strains, 13 
only nucleotides that differ from those in R6 are shown. Nucleotide positions at the 1499-bp 14 
fragments are indicated vertically above the sequences. Nucleotides positions located upstream of 15 
atpC, in atpA, or in atpB are indicated on a white, gray, or black background, respectively. 16 
Colons indicate nucleotides identical to those of the strain R6. SMG are identified by the 17 
corresponding numbering shown in Table 1. Pairwise comparison of the nucleotide sequences 18 
located upstream of atpC (nucleotide positions 1–114) (B), in atpC (nucleotide positions 115–19 
315) (C), atpA (nucleotide positions 350–1066) (D), the conserved part of atpB (nucleotide 20 
positions 1080–1217) (E), and the most divergent region of atpB (nucleotide positions 1218–21 
1499) (F). Matrices of PEDs between aligned sequences are shown. Abbreviations: Spn, S. 22 
pneumoniae R6; Smi, S. mitisT; Sor, S. oralisT. 23 
 22 
FIG. 4. Genetic structure of the atp region and its surrounding regions in streptococci of the 1 
mitis group. Big arrows indicate the genes and their direction of transcription taking as reference 2 
the S. pneumoniae genome (17, 37). The oligonucleotides used in PCR experiments are indicated 3 
by small black arrows (A) Crosshatched and open arrows correspond to the atp genes of S. 4 
pneumoniae (Spn)/S. pseudopneumoniae (Sps) or S. mitis/S. oralis (Smi, Sor), respectively. The 5 
atpB gene from the OptS SMG is represented as a doubly shaded arrow where the gray color 6 
indicates sequence divergence either from S. pneumoniae or S. mitis genes. (B) Partial genomic 7 
map of the DNA regions flanking the S. mitisT operon. The DNA region linking contig 966, 8 
whose complementary and inverted sequence is represented (revContig 966), and contig 1476 is 9 
represented as a dotted line; it has been previously sequenced (23), and corresponds to the S. 10 
mitis/S. oralis scheme shown in A. Genes are named according to their S. pneumoniae R6 11 
homologues. Yellow and pink arrows indicate genes that are translocated as compared with their 12 
location and orientation in S. pneumoniae. Red arrows indicate gene or gene clusters that are 13 
inverted. S. mitis genes showing synteny with those of S. pneumoniae are indicated by green or 14 
open (for the atp genes) arrows. Light blue and solid arrows represent transposase genes or genes 15 
lacking any significant similarity with those included in the databases, respectively. T, B, and R 16 
indicate the location of transposase/IS-like elements, and BOX or RUP repeats, respectively, as 17 
annotated in the S. pneumoniae R6 genome sequence (17). 18 
 23 
 
TABLE 1. Relevant characteristics of the strains used in this study 
   Opt susceptibilityb    
   
Zone size 
(mm) in  
MIC 
(g/ml) in  
Opt 
Phenotype   Presence of 
Strain Origina  API identification CO2 O2 CO2 O2 CO2/O2 
Doc 
phenotype APd lytA ply ant 
578 Nose, sinusitis Sor (98.5%) 15 22 1.5 0.75 S/S +/–  + + + 
1237 BAA, pneumonia, HIV+ Sor (84.4%) 18 21 1.5 0.37 S/S +/–  + + + 
1504 LRT Sor (99.0%) 20 23 1.5 0.75 S/S +/–  + + + 
1956 Sputum, fever Sor (94.9%) 17 24 1.5 0.75 S/S +/–  + + + 
2410 Pus, abscess Sor (89.9%) 15 20 1.5 0.75 S/S +/–  + + + 
2859 Ascites Sor (82.4)% 18 20 1.5 0.75 S/S +/–  + + + 
3137 BAA, pneumonia Sor (53.4%), Spn (32.6%) 16 20 1.5 0.75 S/S +/–  + + + 
3198 Sputum, bronchitis Sor (93.5%) 12 18 3 0.75 IR/S +/–  + + + 
Smi NCTC 12261T    6 6 96 48 R/R     + 
Sor NCTC 11427T    6 6 96 48 R/R     + 
Spn R6   12 19 3 1.5 IR/S + + + +  
Spn ATCC 6303   16 22 1.5 0.75 S/S + + + + – 
Sps CCUG 49455T   10 20 6 1.5 IR/S +/– + + +  
Sps CCUG 48465   12 21 6 0.75 IR/S +/– + + +  
 
a BAA, bronchoalveolar aspirate; LRT, lower respiratory tract 
 24 
b Susceptibility categorizations for OPT  were: resistant, MICs ≥6 g/ml or zone size diameter <10 mm; intermediate, MICs of 3 to 6 g/ml or 
zone size diameter of 10 to 14 mm; susceptible, MICs ≤ 1.5 g/ml  or zone size diameter >14 mm. 
 
 
 
 
 
